• Blog
  • Global Hematology Market Analysis Report | 2022-2027

    Global Hematology Market Analysis Report | 2022-2027

    Global Hematology Market Analysis Report | 2022-2027
    Report code - SRHL119 Delivery - 2 Weeks
    Global Hematology Market Size, Share, Trend, Forecast, Growth & Industry Analysis | 20 See more...

    Hematology Market Insights

    The Global Hematology Market is estimated to grow at a healthy CAGR of 5.5% during the forecast period of 2022-2027.

    Hematology Market Snapshot

    Want to know more about the market scope? Register Here.

    What is hematology?

    Hematology is a branch of medical science that deals with the cause, treatment, prognosis, and prevention of diseases related to blood and blood-forming organs. It involves treating diseases that affect the production of blood and its components, such as blood cells, hemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation.

    Such diseases might include hemophilia, sickle cell anemia, blood clots (thrombus), other bleeding disorders, and blood cancers such as leukemia, multiple myeloma, and lymphoma.

    Global Hematology Market Report Overview

    Market Growth (2022-2027)

    CAGR of 5.5% 

    Base Year of Study

    2021

    Trend Period

    2016-2020

    Forecast Period

    2022-2027

    Leading Product Type

    Hematology Analyzers

    The region with the highest demand

    North America

    Market Drivers

    The hematology market is driven by several factors, including:

    • Growing incidences of blood disorders and other diseases.
    • Increasing importance of hematological testing in COVID-19-infected patients.
    • Rapid technological advancements in hematology.
    • The emergence of high throughput hematology analyzers.

    Key Players

    Some of the major key players in the global hematology market are-

    Segments Analysis

    Product Trends

    Based on the product type, the market is segmented as hematology analyzers, flow cytometers, coagulation analyzers, slide stainers, centrifuges, hemoglobinometers, and others.

    The market for hematology analyzers is expected to register promising gains during the projected period, owing to the rising prevalence of blood-related disorders, which is driving the demand for hematology tests and their technological advancements.

    Regional Analysis

    In terms of regions, North America is estimated to account for the major share of the market during the forecast period, owing to the rising incidences of blood-related disorders and diseases, technological advancements, and an increase in the number of product launches in the region.

    Hematology Market Region

    Want to know which region offers the best growth opportunities? Register Here.

    Europe and Asia-Pacific are also expected to offer substantial growth opportunities during the forecast period. 

    Segmentation

    This report studies the market covering 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

    The global market is segmented into the following categories.

    By Product Type

    • Hematology Analyzers (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Flow Cytometers (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Coagulation Analyzers (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Slide Stainers (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Centrifuges (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Hemoglobinometers (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Others (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

    By Reagent Type

    • Coagulation Reagents (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Flow Cytometry Reagents (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Immuno-Hematology Reagents (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Others (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

    By Application Type

    • Drug Testing (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Auto-immune Diseases (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Cancer (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Diabetes Mellitus (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Infectious Diseases (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Others (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

    By End-User Type

    • Hospitals (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Clinical Testing Institutes (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Patient Self-testing (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)
    • Others (Regional Analysis: North America, Europe, Asia-Pacific, and RoW)

    By Region

    • North America (Country Analysis: the USA, Canada, and Mexico) 
    • Europe (Country Analysis: Germany, France, the UK, Russia, Spain, and Rest of Europe)
    • Asia-Pacific (Country Analysis: China, Japan, India, South Korea, and Rest of Asia-Pacific)
    • Rest of the World (Sub-Region Analysis: Latin America, the Middle East, and Others)

    Report Features

    This report provides market intelligence most comprehensively. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.

    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth analysis of the global hematology market.

    How lucrative is the future?

    The market forecast and trend data and emerging trends.

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts.

    Which are the most attractive market segments?

    Market Segment Analysis and Forecast.

    What are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis.

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, and Life cycle analysis.

    What are the factors affecting the market?

    Drivers & challenges.

    Will I get the information on my specific requirements?

    10% free customization.

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

    We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Target Audience

    The following is a list of the customers that the market aims to convert the most:

    • Manufacturers
    • Suppliers
    • Distributors
    • Organizations
    • Government bodies

    Critical Questions Answered in the Report

    • What are the key trends in the market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the market?
    • What are the key strategies adopted by the major vendors to lead in the market?
    • What is the market share of the top vendors?

    Report Customization Options

    With this detailed report, Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to 3 players)
    • SWOT analysis of key players (up to 3 players)

    Competitive Benchmarking

    • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: 

    Stratview Research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry to sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    Hematology is a branch of medical science that deals with the cause, treatment, prognosis, and prevention of diseases related to blood and blood-forming organs. It involves treating diseases that affect the production of blood and its components, such as blood cells, hemoglobin, blood proteins, bone marrow, platelets, blood vessels, spleen, and the mechanism of coagulation. Such diseases might include hemophilia, sickle cell anemia, blood clots (thrombus), other bleeding disorders, and blood cancers such as leukemia, multiple myeloma, and lymphoma.

    The hematology market is expected to grow at a CAGR of 5.5% during the forecast period.

    Some of the major players in the hematology market are- Abbott Laboratories, Agilent Technologies Inc., Bio-Rad Laboratories Inc., Danaher Corporation, Diatron MI PLC, Drew Scientific Group, F. Hoffmann-La Roche AG, Fluidigm Corporation, Novo Nordisk A/S, and PerkinElmer Inc.

    North America is estimated to account for the major share of the market during the forecast period.

    The market for hematology analyzers is expected to register promising gains during the projected period.

    Growing incidences of blood disorders and other diseases, the increasing importance of hematological testing in COVID-19-infected patients, rapid technological advancements in hematology, and the emergence of high throughput hematology analyzers are some of the major factors expected to drive the growth of the market during the forecast period.